%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Thomas C. Booth, Timothy J. Larkin, Yinyin Yuan, Mikko I. Kettunen, Sarah N. Dawson, Daniel Scoffings, Holly C. Canuto, Sarah L. Vowler, Heide Kirschenlohr, Michael P. Hobson, Florian Markowetz, Sarah Jefferies, Kevin M. Brindle
Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 13 0 R/Contents 14 0 R/TrimBox[0 0 612 792]>>
endobj
13 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref001)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref002)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref003)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref004)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref005)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref006)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref007)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref002)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref008)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref011)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref012)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref013)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref013)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref014)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref015)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.s003)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref002)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref016)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176528.ref017)>>
endobj
34 0 obj
<>/Border[0 0 0]/A 41 0 R>>
endobj
41 0 obj
<>
endobj
35 0 obj
<>/Border[0 0 0]/A 42 0 R>>
endobj
42 0 obj
<>
endobj
36 0 obj
<>/Border[0 0 0]/A 43 0 R>>
endobj
43 0 obj
<>
endobj
37 0 obj
<>/Border[0 0 0]/A 44 0 R>>
endobj
44 0 obj
<>
endobj
38 0 obj
<>/Border[0 0 0]/A 45 0 R>>
endobj
45 0 obj
<>
endobj
39 0 obj
<>/Border[0 0 0]/A 46 0 R>>
endobj
46 0 obj
<>
endobj
40 0 obj
<>/Border[0 0 0]/A 47 0 R>>
endobj
47 0 obj
<>
endobj
14 0 obj
[48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R]
endobj
48 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 680.2299 m
199.9998 680.2299 l
199.9998 680.73 l
575.9997 680.73 l
f*
0.83 0.64 0.02 0 k
369.5244 598.0535 m
374.2866 598.0535 l
h
f*
479.7921 585.0142 m
484.5543 585.0142 l
h
f*
480.5291 546.0094 m
485.2913 546.0094 l
h
f*
301.7764 494.022 m
306.5386 494.022 l
h
f*
434.4945 481.0394 m
439.2567 481.0394 l
h
f*
480.4157 455.0173 m
485.178 455.0173 l
h
f*
487.4457 455.0173 m
492.2079 455.0173 l
h
f*
433.6441 390.0472 m
438.4063 390.0472 l
h
f*
440.6173 390.0472 m
445.3795 390.0472 l
h
f*
450.5953 390.0472 m
460.063 390.0472 l
h
f*
526.0535 377.0646 m
535.5213 377.0646 l
h
f*
456.8882 364.0252 m
466.4126 364.0252 l
h
f*
549.0709 312.0378 m
558.5953 312.0378 l
h
f*
560.863 312.0378 m
570.3874 312.0378 l
h
f*
470.0409 299.0551 m
479.5654 299.0551 l
h
f*
237.0898 146.948 m
270.9921 146.948 l
h
f*
495.6094 133.9087 m
500.3717 133.9087 l
h
f*
203.4142 107.9433 m
212.9386 107.9433 l
h
f*
443.452 81.9213 m
452.9764 81.9213 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
0.0095 Tc
0 0 Td
(change)Tj
3.5388 0 Td
(in)Tj
1.0145 0 Td
(treatment)Tj
4.5294 0 Td
(strategy.)Tj
4.1416 0 Td
(Prospective)Tj
5.5439 0 Td
(validation)Tj
4.5175 0 Td
(of)Tj
1.0742 0 Td
(this)Tj
1.8142 0 Td
(technique)Tj
4.6249 0 Td
(in)Tj
1.0086 0 Td
(larger)Tj
2.8227 0 Td
(datasets)Tj
4.0759 0 Td
(is)Tj
-38.7062 -1.474 Td
(required.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 629.1212 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 612.1133 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(commonest)Tj
4.9266 0 Td
(primary)Tj
3.4582 0 Td
(malignant)Tj
4.2803 0 Td
(brain)Tj
2.3471 0 Td
(tumour,)Tj
3.4979 0 Td
(glioblastoma,)Tj
5.5389 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.6519 0 Td
(devastating)Tj
4.7339 0 Td
(disease)Tj
3.016 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
-37.0769 -1.2982 Td
(progression)Tj
4.9209 0 Td
(free-survival)Tj
5.193 0 Td
(of)Tj
1.0148 0 Td
(15%)Tj
1.9275 0 Td
(at)Tj
0.9525 0 Td
(1)Tj
0.6973 0 Td
(year.[)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(])Tj
3.2825 0 Td
(Maximal)Tj
3.7757 0 Td
(debulking)Tj
4.235 0 Td
(surgery)Tj
3.1917 0 Td
(and)Tj
1.7292 0 Td
(radiotherapy,)Tj
-30.9201 -1.3039 Td
(with)Tj
1.9955 0 Td
(concomitant)Tj
5.2951 0 Td
(and)Tj
1.7291 0 Td
(adjuvant)Tj
3.7021 0 Td
(temozolomide,)Tj
6.2078 0 Td
(is)Tj
0.8447 0 Td
(the)Tj
1.474 0 Td
(standard)Tj
3.7191 0 Td
(of)Tj
1.0147 0 Td
(care[)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(])Tj
3.0274 0 Td
(but)Tj
1.5534 0 Td
(is)Tj
0.8504 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
-35.6709 -1.2983 Td
(pseudoprogression.)Tj
8.0106 0 Td
(This)Tj
1.9842 0 Td
(describes)Tj
3.8835 0 Td
(false-positive)Tj
5.4198 0 Td
(progressive)Tj
4.7452 0 Td
(disease)Tj
3.016 0 Td
(within)Tj
2.812 0 Td
(6)Tj
0.6973 0 Td
(months)Tj
3.2825 0 Td
(of)Tj
1.0148 0 Td
(che-)Tj
-34.8659 -1.2983 Td
(moradiotherapy,)Tj
6.9051 0 Td
(typically)Tj
3.5603 0 Td
(determined)Tj
4.8529 0 Td
(by)Tj
1.1792 0 Td
(changes)Tj
3.4072 0 Td
(in)Tj
1.0318 0 Td
(contrast)Tj
3.4639 0 Td
(enhancement)Tj
5.6409 0 Td
(on)Tj
/F11 1 Tf
1.2756 0 Td
[()]TJ
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 519.0803 558.4251 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(1)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 522.6519 560.1259 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(-weighted)Tj
-32.2637 -1.3039 Td
(MR)Tj
1.7348 0 Td
(images,)Tj
3.2145 0 Td
(representing)Tj
5.2384 0 Td
(non-specific)Tj
5.1477 0 Td
(blood-brain)Tj
4.9889 0 Td
(barrier)Tj
2.965 0 Td
(disruption.[)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(])Tj
5.7997 0 Td
(Pseudoprogression)Tj
-29.089 -1.2982 Td
(confounds)Tj
4.4561 0 Td
(response)Tj
3.736 0 Td
(assessment)Tj
4.6091 0 Td
(and)Tj
1.7291 0 Td
(may)Tj
1.9276 0 Td
(affect)Tj
2.3754 0 Td
(clinical)Tj
3.0784 0 Td
(management.)Tj
5.6579 0 Td
(An)Tj
1.457 0 Td
(imaging)Tj
3.4865 0 Td
(technique)Tj
-32.5131 -1.2983 Td
(that)Tj
1.7745 0 Td
(reliably)Tj
3.1748 0 Td
(differentiates)Tj
5.4368 0 Td
(responders)Tj
4.6318 0 Td
(from)Tj
2.2053 0 Td
(non-responders)Tj
6.5877 0 Td
(would)Tj
2.7156 0 Td
(allow)Tj
2.3357 0 Td
(an)Tj
1.2019 0 Td
(early)Tj
2.1486 0 Td
(change)Tj
3.0443 0 Td
(in)Tj
-35.257 -1.2983 Td
(treatment)Tj
4.1329 0 Td
(strategy)Tj
3.3279 0 Td
(with)Tj
1.9955 0 Td
(prompt)Tj
3.2542 0 Td
(termination)Tj
5.0003 0 Td
(of)Tj
1.0148 0 Td
(ineffective)Tj
4.3256 0 Td
(treatment)Tj
4.1386 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4683 0 Td
(option)Tj
2.8686 0 Td
(of)Tj
1.0148 0 Td
(imple-)Tj
-34.2706 -1.3039 Td
(menting)Tj
3.5887 0 Td
(novel)Tj
2.4037 0 Td
(therapies.[)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(])Tj
5.2214 0 Td
(To)Tj
1.3379 0 Td
(achieve)Tj
3.1748 0 Td
(this,)Tj
1.8992 0 Td
(we)Tj
1.3266 0 Td
(describe)Tj
3.5263 0 Td
(a)Tj
0.652 0 Td
(method)Tj
3.3278 0 Td
(that)Tj
1.7745 0 Td
(is)Tj
0.8504 0 Td
(simple)Tj
2.8516 0 Td
(to)Tj
1.0261 0 Td
(implement,)Tj
-32.961 -1.2982 Td
(requires)Tj
3.4696 0 Td
(little)Tj
2.0012 0 Td
(computational)Tj
6.0491 0 Td
(effort,)Tj
2.6192 0 Td
(is)Tj
0.8504 0 Td
(intuitive)Tj
3.5717 0 Td
(to)Tj
1.0261 0 Td
(interpret[)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(])Tj
4.8926 0 Td
(and)Tj
1.7348 0 Td
(only)Tj
1.9729 0 Td
(requires)Tj
/F11 1 Tf
3.4752 0 Td
[()]TJ
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 522.5385 480.4724 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 526.1102 482.1165 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(-weighted)Tj
-32.6095 -1.2982 Td
(images)Tj
2.9877 0 Td
(that)Tj
1.7801 0 Td
(are)Tj
1.4457 0 Td
(acquired)Tj
3.702 0 Td
(routinely)Tj
3.8665 0 Td
(during)Tj
2.931 0 Td
(patient)Tj
3.0047 0 Td
(follow-up)Tj
4.0932 0 Td
(and)Tj
1.7291 0 Td
(which)Tj
2.6532 0 Td
(more)Tj
2.3414 0 Td
(accurately)Tj
4.2575 0 Td
(detect)Tj
-34.7921 -1.3039 Td
(glioblastoma)Tj
5.3121 0 Td
(infiltration)Tj
4.5581 0 Td
(than)Tj
2.0296 0 Td
(contrast-enhanced)Tj
/F11 1 Tf
7.6705 0 Td
[()]TJ
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 401.6125 454.4503 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(1)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 405.1842 456.0944 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(-weighted)Tj
4.1895 0 Td
(images.[)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(;)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(])Tj
5.0683 0 Td
(This)Tj
1.99 0 Td
(is)Tj
0.8447 0 Td
(because)Tj
-32.6095 -1.2982 Td
(glioblastoma)Tj
5.3121 0 Td
(cell)Tj
1.5591 0 Td
(infiltration,)Tj
4.7848 0 Td
(which)Tj
2.6532 0 Td
(can)Tj
1.6271 0 Td
(cause)Tj
2.3867 0 Td
(hyperintensity)Tj
5.981 0 Td
(in)Tj
/F11 1 Tf
1.0375 0 Td
[()]TJ
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 459.3259 441.4677 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 462.8976 443.1118 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(-weighted)Tj
4.1839 0 Td
(images,)Tj
3.2201 0 Td
(does)Tj
-33.6923 -1.2982 Td
(not)Tj
1.5704 0 Td
(necessarily)Tj
4.5354 0 Td
(result)Tj
2.4491 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(blood-brain)Tj
4.9946 0 Td
(barrier)Tj
2.9651 0 Td
(disruption)Tj
4.4106 0 Td
(required)Tj
3.6396 0 Td
(for)Tj
1.389 0 Td
(detection)Tj
3.9344 0 Td
(in)Tj
1.0375 0 Td
(contrast-)Tj
-33.4315 -1.3039 Td
(enhanced)Tj
/F11 1 Tf
4.0762 0 Td
[()]TJ
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 246.6708 415.4456 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(1)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 250.2425 417.0897 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(-weighted)Tj
4.1839 0 Td
(images.)Tj
3.2201 0 Td
(Analysis)Tj
3.5773 0 Td
(of)Tj
/F11 1 Tf
1.0148 0 Td
[()]TJ
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 376.1007 415.4456 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 379.6157 417.0897 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(-weighted)Tj
4.1895 0 Td
(images)Tj
2.9934 0 Td
(to)Tj
1.0205 0 Td
(determine)Tj
4.3256 0 Td
(treatment)Tj
-30.4892 -1.2982 Td
(response)Tj
3.7304 0 Td
(is)Tj
0.8504 0 Td
(therefore)Tj
3.8551 0 Td
(now)Tj
1.9559 0 Td
(routine)Tj
3.1634 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(clinic,)Tj
2.6248 0 Td
(although)Tj
3.7531 0 Td
(the)Tj
1.4683 0 Td
(detail)Tj
2.4151 0 Td
(of)Tj
1.0148 0 Td
(how)Tj
1.9389 0 Td
(to)Tj
1.0261 0 Td
(determine)Tj
-30.3021 -1.2983 Td
(response)Tj
3.7304 0 Td
(from)Tj
2.2054 0 Td
(these)Tj
2.2563 0 Td
(images)Tj
2.9877 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.652 0 Td
(topic)Tj
2.2337 0 Td
(of)Tj
1.0148 0 Td
(ongoing)Tj
3.5318 0 Td
(research.[)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(;)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(])Tj
7.1036 0 Td
(Our)Tj
1.8652 0 Td
(approach)Tj
3.9514 0 Td
(exploits)Tj
3.3052 0 Td
(the)Tj
-35.6879 -1.2982 Td
(fact)Tj
1.6611 0 Td
(that)Tj
1.7802 0 Td
(tissue)Tj
2.4604 0 Td
(morphology)Tj
5.1421 0 Td
(can)Tj
1.627 0 Td
(be)Tj
1.1509 0 Td
(a)Tj
0.652 0 Td
(sensitive)Tj
3.6225 0 Td
(marker)Tj
3.1351 0 Td
(of)Tj
1.0148 0 Td
(underlying)Tj
4.6034 0 Td
(tissue)Tj
2.4605 0 Td
(biology[)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(])Tj
4.8019 0 Td
(and)Tj
1.7291 0 Td
(that)Tj
-35.841 -1.304 Td
(morphological)Tj
6.0605 0 Td
(information)Tj
5.074 0 Td
(can)Tj
1.627 0 Td
(be)Tj
1.1509 0 Td
(extracted)Tj
3.8834 0 Td
(from)Tj
2.2053 0 Td
(an)Tj
1.2019 0 Td
(MR)Tj
1.7348 0 Td
(image[)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(])Tj
4.2632 0 Td
(using)Tj
2.3868 0 Td
(image)Tj
2.6305 0 Td
(descriptors)Tj
-32.2183 -1.2982 Td
(called)Tj
2.5172 0 Td
(Minkowski)Tj
4.7452 0 Td
(functionals)Tj
4.6658 0 Td
(\(MFs\).)Tj
2.9083 0 Td
(MFs)Tj
2.0012 0 Td
(can)Tj
1.627 0 Td
(be)Tj
1.1509 0 Td
(used)Tj
2.0579 0 Td
(to)Tj
1.0261 0 Td
(parameterize)Tj
5.4142 0 Td
(the)Tj
1.474 0 Td
(heterogeneous)Tj
-29.5878 -1.2983 Td
(distribution)Tj
4.9663 0 Td
(of)Tj
1.0148 0 Td
(hyper-)Tj
2.8687 0 Td
(and)Tj
1.7291 0 Td
(hypointense)Tj
5.0966 0 Td
(foci)Tj
1.7065 0 Td
(in)Tj
/F11 1 Tf
1.0317 0 Td
[()]TJ
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 390.0472 337.4362 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 393.6188 339.137 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(-weighted)Tj
4.1895 0 Td
(tumour)Tj
3.2712 0 Td
(images)Tj
2.9877 0 Td
(and)Tj
1.7348 0 Td
(have)Tj
2.0579 0 Td
(been)Tj
-33.6016 -1.3039 Td
(shown)Tj
2.846 0 Td
(recently)Tj
3.4129 0 Td
(to)Tj
1.0205 0 Td
(be)Tj
1.1508 0 Td
(capable)Tj
3.2088 0 Td
(of)Tj
1.0148 0 Td
(detecting)Tj
3.8948 0 Td
(treatment)Tj
4.1328 0 Td
(response)Tj
3.736 0 Td
(through)Tj
3.4469 0 Td
(changes)Tj
3.4016 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(size)Tj
-33.7717 -1.2982 Td
(and)Tj
1.7292 0 Td
(distribution)Tj
4.9662 0 Td
(of)Tj
1.0148 0 Td
(these)Tj
2.2564 0 Td
(foci)Tj
1.7064 0 Td
(in)Tj
1.0318 0 Td
(pre-clinical)Tj
4.7395 0 Td
(MR)Tj
1.7348 0 Td
(images,)Tj
3.2144 0 Td
(including)Tj
/F11 1 Tf
4.0422 0 Td
[()]TJ
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 470.2677 311.4708 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 473.8393 313.1149 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(-weighted)Tj
4.1895 0 Td
(images.[)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(;)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(])Tj
-31.572 -1.2982 Td
(Previously)Tj
4.3937 0 Td
(applied)Tj
3.1521 0 Td
(to)Tj
1.0262 0 Td
(describe)Tj
3.5206 0 Td
(the)Tj
1.4683 0 Td
(complex)Tj
3.6227 0 Td
(morphology)Tj
5.1476 0 Td
(of)Tj
1.0148 0 Td
(galaxies,[)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(])Tj
5.1703 0 Td
(MFs)Tj
2.0012 0 Td
(can)Tj
1.6271 0 Td
(capture)Tj
-32.1446 -1.3039 Td
(underlying)Tj
4.5978 0 Td
(tumour)Tj
3.2712 0 Td
(heterogeneity)Tj
5.6522 0 Td
(not)Tj
1.5761 0 Td
(apparent)Tj
3.7644 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4683 0 Td
(reporting)Tj
3.9912 0 Td
(radiologist.)Tj
4.694 0 Td
(The)Tj
1.7858 0 Td
(purpose)Tj
3.4413 0 Td
(of)Tj
-35.2684 -1.2983 Td
(this)Tj
1.6725 0 Td
(study)Tj
2.3924 0 Td
(was)Tj
1.6951 0 Td
(to)Tj
1.0261 0 Td
(extend)Tj
2.9084 0 Td
(the)Tj
1.4683 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(MFs)Tj
2.0013 0 Td
(to)Tj
1.0261 0 Td
(clinical)Tj
3.0784 0 Td
(MRI)Tj
2.0749 0 Td
(data)Tj
1.9106 0 Td
(and)Tj
1.7348 0 Td
(develop)Tj
3.3164 0 Td
(an)Tj
1.2019 0 Td
(imaging)Tj
3.4866 0 Td
(technique)Tj
-33.5393 -1.2983 Td
(that)Tj
1.7745 0 Td
(can)Tj
1.6271 0 Td
(distinguish)Tj
4.6374 0 Td
(pseudoprogressi)Tj
6.514 0 Td
(on)Tj
1.2756 0 Td
(from)Tj
2.2053 0 Td
(true)Tj
1.8369 0 Td
(progression)Tj
4.9209 0 Td
(by)Tj
1.1849 0 Td
(analysing)Tj
3.9797 0 Td
(heterogeneity)Tj
5.6522 0 Td
(in)Tj
/F11 1 Tf
-35.6085 -1.3039 Td
[()]TJ
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 205.9086 246.444 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 209.4803 248.0881 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(-weighted)Tj
4.1839 0 Td
(MR)Tj
1.7348 0 Td
(images.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 222.0094 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Methods)Tj
/F0 1 Tf
0 -1.5023 Td
(Participants)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 186.9732 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(UK)Tj
1.6327 0 Td
(National)Tj
3.6907 0 Td
(Research)Tj
3.8041 0 Td
(Ethics)Tj
2.6702 0 Td
(Service)Tj
3.0557 0 Td
(approved)Tj
3.9742 0 Td
(the)Tj
1.4683 0 Td
(retrospective)Tj
5.3631 0 Td
(and)Tj
1.7292 0 Td
(prospective)Tj
4.7848 0 Td
(arms)Tj
2.2054 0 Td
(of)Tj
-36.1585 -1.2982 Td
(the)Tj
1.4683 0 Td
(study)Tj
2.3867 0 Td
(\(written)Tj
3.4526 0 Td
(or)Tj
1.0999 0 Td
(verbal)Tj
2.6588 0 Td
(informed)Tj
3.9685 0 Td
(consent)Tj
3.3335 0 Td
(to)Tj
1.0262 0 Td
(participate)Tj
4.4673 0 Td
(in)Tj
1.0375 0 Td
(this)Tj
1.6725 0 Td
(study,)Tj
2.6191 0 Td
(which)Tj
2.6476 0 Td
(used)Tj
2.0636 0 Td
(de-iden-)Tj
-33.9021 -1.2983 Td
(tified)Tj
2.2903 0 Td
(data,)Tj
2.1373 0 Td
(was)Tj
1.7008 0 Td
(not)Tj
1.5761 0 Td
(a)Tj
0.6519 0 Td
(requirement)Tj
5.2044 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4684 0 Td
(UK)Tj
1.6327 0 Td
(National)Tj
3.6907 0 Td
(Research)Tj
3.8041 0 Td
(Ethics)Tj
2.6702 0 Td
(Service\).)Tj
3.6226 0 Td
(Eligible)Tj
-31.6287 -1.2982 Td
(patients)Tj
3.3675 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(S1)Tj
1.508 0 Td
(Table)Tj
0 g
(\))Tj
2.7836 0 Td
(were)Tj
2.126 0 Td
(those)Tj
2.3357 0 Td
(with)Tj
1.9956 0 Td
(recently)Tj
3.4129 0 Td
(diagnosed)Tj
4.2803 0 Td
(glioblastoma)Tj
5.3121 0 Td
(who)Tj
1.9389 0 Td
(underwent)Tj
4.575 0 Td
(chemora-)Tj
-33.6356 -1.304 Td
(diotherapy)Tj
4.5467 0 Td
(according)Tj
4.1896 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4683 0 Td
(Stupp)Tj
2.5569 0 Td
(regimen)Tj
3.5376 0 Td
(on)Tj
1.2756 0 Td
(an)Tj
1.2019 0 Td
(intention-to-treat)Tj
7.2623 0 Td
(basis.[)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(])Tj
3.5263 0 Td
(All)Tj
1.4003 0 Td
(patients)Tj
3.3675 0 Td
(com-)Tj
-35.3591 -1.2982 Td
(pleted)Tj
2.6532 0 Td
(a)Tj
0.6576 0 Td
(6)Tj
0.6916 0 Td
(week)Tj
2.2507 0 Td
(radiotherapy)Tj
5.3518 0 Td
(course)Tj
2.8346 0 Td
(of)Tj
1.0148 0 Td
(60)Tj
1.1736 0 Td
(Gy)Tj
1.3889 0 Td
(in)Tj
1.0375 0 Td
(30)Tj
1.1679 0 Td
(fractions,)Tj
3.9458 0 Td
(following)Tj
3.9798 0 Td
(institutional)Tj
5.091 0 Td
(protocol,)Tj
-33.2388 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(])Tj
1.8481 0 Td
(except)Tj
2.7723 0 Td
(for)Tj
1.389 0 Td
(one)Tj
1.6951 0 Td
(patient)Tj
3.0103 0 Td
(who)Tj
1.9389 0 Td
(received)Tj
3.532 0 Td
(60)Tj
1.1735 0 Td
(Gy)Tj
1.389 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(planning)Tj
3.7984 0 Td
(target)Tj
2.5114 0 Td
(volume)Tj
3.1975 0 Td
(and)Tj
1.7291 0 Td
(80)Tj
1.1736 0 Td
(Gy)Tj
1.3889 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
-36.0678 -1.3039 Td
(gross)Tj
2.2847 0 Td
(tumour)Tj
3.2711 0 Td
(volume.)Tj
3.4243 0 Td
(Patients)Tj
3.4072 0 Td
(entered)Tj
3.2371 0 Td
(into)Tj
1.8425 0 Td
(drug)Tj
2.1147 0 Td
(trials)Tj
2.194 0 Td
(were)Tj
2.1259 0 Td
(excluded)Tj
3.7814 0 Td
(and)Tj
1.7348 0 Td
(bevacuzimab)Tj
5.4312 0 Td
(was)Tj
-34.8489 -1.2983 Td
(not)Tj
1.5703 0 Td
(prescribed)Tj
4.4164 0 Td
(in)Tj
1.0375 0 Td
(keeping)Tj
3.3562 0 Td
(with)Tj
2.0012 0 Td
(European)Tj
4.1159 0 Td
(recommendations.[)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(])Tj
/F11 1 Tf
9.3599 0 Td
[()]TJ
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 464.485 81.3543 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 468.0566 82.9984 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(-weighted)Tj
4.1839 0 Td
(images)Tj
2.9933 0 Td
(were)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 420.6047 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Detecti)Tj
3.0543 0 Td
(ng)Tj
1.311 0 Td
(pseudoprogr)Tj
5.5135 0 Td
(ession)Tj
3.0543 0 Td
(in)Tj
0.978 0 Td
(glioblastom)Tj
4.9607 0 Td
(a)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01765)Tj
4.089 0 Td
(28)Tj
0 g
2.0906 0 Td
(May)Tj
2.0906 0 Td
(17,)Tj
1.5803 0 Td
(2017)Tj
35.2349 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(20)Tj
ET
Q
q
0.83 0.64 0.02 0 k
1 j
1 J
0 w
102.0472 696.6425 m
168.2079 696.6425 l
h
f*
85.1528 613.6441 m
131.6409 613.6441 l
h
f*
135.2126 613.6441 m
152.5606 613.6441 l
h
f*
36 602.6457 m
102.3307 602.6457 l
h
f*
105.9024 602.6457 m
140.7685 602.6457 l
h
f*
36 591.6472 m
111.4016 591.6472 l
h
f*
0 g
7.9999 0 0 7.9999 36 708.7181 cm
BT
/F9 1 Tf
1 TL
-0.025 Tc
0 0 Td
(give)Tj
1.7291 0 Td
(permission.)Tj
4.578 0 Td
(Interest)Tj
2.8063 0 Td
(ed)Tj
1.1197 0 Td
(researche)Tj
3.6142 0 Td
(rs)Tj
0.9496 0 Td
(may)Tj
-14.7969 -1.3748 Td
(contact)Tj
2.9409 0 Td
(this)Tj
1.5662 0 Td
(agency)Tj
2.8488 0 Td
(at)Tj
0.83 0.64 0.02 0 k
0.9 0 Td
(HRA.Queri)Tj
3.9048 0 Td
(es@nhs.ne)Tj
4.1032 0 Td
(t)Tj
0 g
(.)Tj
/F8 1 Tf
-16.2639 -2.126 Td
(Funding:)Tj
/F9 1 Tf
3.5716 0 Td
(Funded)Tj
2.9552 0 Td
(by)Tj
1.1126 0 Td
(Medical)Tj
3.1039 0 Td
(Researc)Tj
2.9977 0 Td
(h)Tj
0.6945 0 Td
(Council/)Tj
-14.4355 -1.3748 Td
(Royal)Tj
2.3173 0 Td
(College)Tj
2.9197 0 Td
(of)Tj
0.9496 0 Td
(Radiologists)Tj
4.7977 0 Td
(\(UK\))Tj
1.9488 0 Td
(Clinical)Tj
-12.9331 -1.3748 Td
(Research)Tj
3.6992 0 Td
(Fellows)Tj
2.7567 0 Td
(hip)Tj
1.3606 0 Td
(\(G1000265\);)Tj
4.9607 0 Td
(Cancer)Tj
-12.7772 -1.3748 Td
(Research)Tj
3.6992 0 Td
(UK)Tj
1.3323 0 Td
(Clinical)Tj
2.8276 0 Td
(Research)Tj
3.6992 0 Td
(Fellowship;)Tj
-11.5583 -1.3748 Td
(Addenbrook)Tj
4.5142 0 Td
(es)Tj
1.063 0 Td
(Charitable)Tj
3.9047 0 Td
(Trust)Tj
2.1544 0 Td
(Award)Tj
2.5866 0 Td
(to)Tj
0.9496 0 Td
(TCB.)Tj
-15.1725 -1.3748 Td
(Cancer)Tj
2.7921 0 Td
(Researc)Tj
2.9977 0 Td
(h)Tj
0.6945 0 Td
(UK)Tj
1.3322 0 Td
(Programme)Tj
4.6631 0 Td
(grant)Tj
2.1472 0 Td
(\(C197/)Tj
-14.6268 -1.3748 Td
(A3514\))Tj
2.948 0 Td
(to)Tj
0.9496 0 Td
(KMB.)Tj
0.83 0.64 0.02 0 k
2.2465 0 Td
(www.mrc)Tj
3.6213 0 Td
(.ac.uk)Tj
0 g
(;)Tj
0.83 0.64 0.02 0 k
2.6362 0 Td
(www.)Tj
-12.4016 -1.3749 Td
(cancerres)Tj
3.6142 0 Td
(earchuk.org/)Tj
0 g
(;)Tj
0.83 0.64 0.02 0 k
5.1236 0 Td
(http://ww)Tj
3.4654 0 Td
(w.)Tj
-12.2032 -1.3748 Td
(act4addenbr)Tj
4.6134 0 Td
(ookes.org.u)Tj
4.3866 0 Td
(k)Tj
0 g
(.)Tj
0.8717 0 Td
(The)Tj
1.5874 0 Td
(funders)Tj
3.0402 0 Td
(had)Tj
1.5945 0 Td
(no)Tj
1.1622 0 Td
(role)Tj
-17.256 -1.3748 Td
(in)Tj
0.8858 0 Td
(study)Tj
2.2677 0 Td
(design,)Tj
2.8985 0 Td
(data)Tj
1.7929 0 Td
(collection)Tj
3.7347 0 Td
(and)Tj
1.5945 0 Td
(analysis)Tj
2.9622 0 Td
(,)Tj
-16.1363 -1.3748 Td
(decision)Tj
3.2882 0 Td
(to)Tj
0.9496 0 Td
(publish,)Tj
3.1465 0 Td
(or)Tj
0.9992 0 Td
(preparation)Tj
4.4433 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
-13.7764 -1.3748 Td
(manuscript.)Tj
/F8 1 Tf
0 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F9 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(have)Tj
1.963 0 Td
(declared)Tj
-14.7827 -1.3748 Td
(that)Tj
1.6228 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interests)Tj
ET
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
endstream
endobj
56 0 obj
<>stream
endstream
endobj
57 0 obj
<>stream
endstream
endobj
58 0 obj
<>stream
endstream
endobj
59 0 obj
<>stream
endstream
endobj
60 0 obj
<>stream
endstream
endobj
61 0 obj
<>stream
endstream
endobj
62 0 obj
<>stream
endstream
endobj
63 0 obj
<>stream
endstream
endobj
64 0 obj
<>stream
endstream
endobj
65 0 obj
<>stream
endstream
endobj
66 0 obj
<>stream
endstream
endobj
67 0 obj
<>stream
BT
10.3394 -22.1245 Td
(exist.)Tj
ET
Q
endstream
endobj
68 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 70 0 R/Contents 71 0 R/TrimBox[0 0 612 792]>>
endobj
69 0 obj
<>stream
xwoGU7G{b7ɥ{ɽQOE,6%P
"(\B]}·~sΞ?f͚5k1-0Z`hF-0Z`hF-0Z`hF-0Z`hF-0Z`hF-0Z`hF-0Z`hF-0Z`h;o{~~ܵ2
-0Z`hF-][[я~<_eygFW}?(jTB;XR;SDZZ\%ySBTh
œk~;݈(y?MHIWcҤS*t)NYRČ`Q)K&m-0Z`hF po`U껺#~{r:J,_
yQRM3ooBB(뗨 ooɈ
Ny7{~-<(U7z7*!v"U/((y"℈t"u^uTuX[GDxE"0:@NGt%Jjcbh#R[1>Z`hF-mo09OE+c0W=t'£,Y:&CGOY%p$D|fWy4lRSTdE4PJ$(@'9^K~.ojSѥЉA'0UI+4rB!R$Y5^Ig%EyE6(.2v2*zB yM;!@kynrV2JZj1iidG38In04'SӜOά9qF1sq ,ŜWqiqI˅_\Oy؊4 ťF,Bz5}^:y gDUEe)a/X;Ntvl3cky@DHƈ)YWN)_GH4fb.q{ׇ}؇9\Rl=W5m-oRMD1L#-o&g=8Z`v,9\X$L8y#D%rוHFE^KbƟrQh㉂oex)pA^!&+U\B\~A"%^Pz⪐P%VSRI!QM@]T
'!8O5Ę3ExF8"xPg`2ܖ~lJo&ޗzr)}ڧ-]M0꣖6Ozғԧ[ƌ-`/=y;aH \]yxy/OBPg9G8+89)Xn0uS+a?:ǵ ORDf$W\^H&TtHAGTb̙3^/y1K"ƣ]b۽VoV6(LP/n"eTDRD0fL'S6 $'S$a+jhP&t([5V\s;˿+U|W}՟wnBGt`Ǘ%k
~WooiçŚȿKԙ+ ig>__n͓}iw}wo6r&4;9}c~kkmn-{Ϩ[7u,1WNcES1lQD:
E?ٳΝaʯJ䖼///_M8E|e/ ˾!W||G// yx+LduQu!UwT1h%lyt*5ved2xMjb]^AEpH;JZTء鈽n_uWyu-8\G:ҖٖLah̩^))Go25cwa7i,p3?35m{=^'/c4+_J ŌA&}ߗ.%,vЯ?)OҌ9vZXmgbsx)+4/o2jtⴲc.4cc&
8r"0cC1"짙B$\RЉ4p"F8eRnBIq5v8:\y__
|<-?+?I
$u_uy̹+Dkɓω]ēoo'"R&+cГ\
Uq@}wb(a= %L2~v]C#&.3ᔄ9iGW[]B#3Ek",(-Ntө"Pڊ?O7?^;כSC//[#=__Gg̾/m[yD`7g*`f2o8'<,vߝ:yIߛSlT@Ӡyԩ[oov뮻nۆ䜳GG6_Uք0qZa,8GoKyh.M[z !}@PL+hy]M'wbd&iqnu/D!Xufۛf#g6Y+$/EcNxSD@ÎV&tBވ[S8mY.DÙO$pèt[[<䪫}пkA1GF`G廾#beUX`(`OOpj2srN8BCNw\SV#x-LnRzeКHC\T4yJMG;|X&FJϬymӐV+G)(߭?~scqLBItkwwsz@nNr?1b}pEj@G>}s
"m283g;Ӥ-JM ##xm"g4X$S6?:S\{ӞviX\g<
1a[AKi$ÅW.tMGP{2,jWnv3^GfN2aͩ7qx_Ϊ0^%&RQbvn#;Z9Pyy6tp(T:zc
^nǩqD=dO~2@Mۉf]Ɲ4g3;ĢUr;<;!rl8*UCFܚ%-[lNr4эl)~(U^hr0U\RÐWx .?wA #?
"
7M8I~2!JӜ%q@*84-X]\R#z&!rN/z5*A\{!:ukB"EgIcꤊ3i]LqB"DXaγ#^"&__s˧>Q_EfQ@&,C,
/UjO>ݯ5[:L?
N+ݠk)佼/}D7R۠H3ÐŦc\ggInC_&p}1
ӳbbS/ooJW|wyΛٟ۟c;ùks&j&oQ0x51ʍus/-X
ª#`#P??Qr0k *lېL0iGSNlMl"ϻs
ٟ"GGvi,77&F
z./Oh1ue)pWm2wd:As^5Yk1YhiK)ex=WmIγ4XڱW-Tj3z1'MBYFqt%%UF,7"U}B"P3I2ܪ"@}M_I'#gϞ#3g5WZBةSoA'4TRuLȋ*%^?e x
r:Ps>s{rVhK?Tq*H/ trNFFiXE-ԅTM;S[g5GER)B4AM"?d9UrЇrZ}}YcVҶEOoAD[];.}m%:r~YSK1mr-qҚhP?%=oa:<{5i6k'_ՙUuF&Ѿ56W$3-_?pLlPmlN xhfw~wLٛ3͙G&Jޭe#ofY`p:h3+ Rqk_
=
@fSN+⬒v?riqƱ8W 3 Ji+V:5OE7ʸVթ\(iŃn#Ԣ=3 M2"mX6e6
Hh8Gp& B
\S}AT'5OlKC`~^I#b,fIdUߊȡFzQAW%,UvX&Xx--fG2bd
s=~BǗ1֚+P/7CòҶi゙s7_;ƆjG- 93\'>V=8z'YL&1qē}uZGChf초!kQƢ1mD9avǘi(ZdZ4MhLfZ۳6v:Cވ˄fw YVQ`μGupab'([L m۠;;[9Fs6KI]0`vfucr3p3M7xW8\-%vp8Ru?Mt$
:*e?C?l6H+?֮T~ǑKMZmZE=ds
8:3N`[pFB&c
-^)l(*`"9:,@d6WyO+
+SWH:JJheQRv%yD* b
|K&rE=9Pd AOe '=ٗswtM6c(;U3~$>I@1xZ6DItk-BB$uK]Dڼa#c*pEVζPq9}%Wlb1v8wi!]5挻;oca˽~:4m2.rqn,mƚm5sy 6!vWhNhGnEIϞ
7 t[
`ȸbF[xN/]QfR<1Τ>
ҶX,,#g^3@t~x~ۇڞ??vnN
(F!zOXSq䬳sɽPfAVpkouǧg0UF}Wg@@ۮ~|!mvS>̍ǁ5^W]i+6k{ѕ]Yt,B?\L3EKQg"UgBD (R tOlҌ*4(`z8 4%nB?S?e{Fk4!䠌C5E^I$(I$"r*N2yȘmҟ´ŏ'`6 dž_q $Gg6c
$!suTJw,
a5bI懆eW"4a30ȋ5P*I$I?!_E'\ŋ'r
1s7,%a۟`yWqZ)RGݨcUVUe'byz{+='&nL̂ȝso'h9Gw5Z}~ZݷI7/xMfE]nNmFƸEA'ۥ/r
7da[N9:mz跮ɭ>F~8yc'OmE$ۈ*)^ߤ8LF&.7r
>N3)Zߜ淠;qA?c?Np|1кxkr^+:÷TEy
R}Ɛt)љi-{ܞM} >~'Ř
@_|]}o@b^oDKjnmLO{v9iBgRt]>jK\<fzBS.,qɖdbEB0'IqkJmϹ#
) zpyϸuwϣGT8IAl5TRy
k="lj!ɽ'wN
vB
PdIDQ()FCmA\*䡕>lvrA 61s:Zc py(lӫ,:(!:b1MݫNIN<
. gMATETؖ!l.YXLf0i9w235}ZgXvU߉w`4\t*]{`+q;"[ezV
~ewH1&Cf8m4OMQf4 ҹ=Ŧw]t8mJn
IA,)s]hl[ٳ>yhD\EP}8X4)ѵ4t=cJiYᔛiv S͞FPKsmg7
-⤀5S2n(Jں={fYebķ kŝ 3Oib)q25*,^~pƹ@
9Hm&".8ݭhƻ>54$+\W}HQKZ_p1$T.;i;Da#=CdAhxf,n(bAߢU^ͥqZ9}=!zb,A
(0\K Z)CUDlt@Ӕn ԩSz WHҜONC!*Qz&Of)w@`(2^8]ko,ࣹ&]5g&h"~X`
R#ܯ'i)3zmZ+b2ᝦ]̍qG>̙TLN'n